Inflammatory bowel diseases Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1996	Current medical therapy for inflammatory bowel disease.	+	-	nl	South Med J 89(6):556-66 (1996)
2	2008	Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases.	+	-	nl	J Intern Med 263(6):597-606 (2008)
3	2002	Inflammatory bowel disease: new insights into pathogenesis and treatment.	+	-	nl	J Intern Med 252(6):475-96 (2002)
4	2009	Update in inflammatory bowel disease.	+	-	nl	Aust Fam Physician 38(12):956-61 (2009)
5	2009	The diagnosis and treatment of Crohn's disease and ulcerative colitis.	+	-	nl	Dtsch Arztebl Int 106(8):123-33 (2009)
6	2007	Cutaneous manifestations of inflammatory bowel disease.	+	-	nl	Saudi J Gastroenterol 13(4):159-62 (2007)
7	2000	Hepatobiliary manifestations of inflammatory bowel disease.	+	-	nl	HPB Surg 11(6):363-71 (2000)
8	2009	Pain and inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 15(5):778-88 (2009) Bielefeldt K
9	2009	Molecular bases of impaired water and ion movements in inflammatory bowel diseases.	+	-	nl	Inflamm Bowel Dis 15(1):114-27 (2009)
10	2009	Intestinal barrier dysfunction in inflammatory bowel diseases.	+	-	nl	Inflamm Bowel Dis 15(1):100-13 (2009)
11	2008	Phagocyte dysfunction and inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 14(10):1443-52 (2008)
12	2007	Mycophenolate mofetil therapy for refractory inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 13(12):1488-92 (2007)
13	2007	Defensins and Paneth cells in inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 13(10):1284-92 (2007)
14	2007	Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance.	+	-	nl	Inflamm Bowel Dis 13(8):1016-23 (2007)
15	2006	Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.	+	-	nl	Inflamm Bowel Dis 12(4):311-27 (2006)
16	2007	Genetics of the innate immune response in inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 13(3):338-55 (2007)
17	2007	Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 13(2):129-34 (2007)
18	2006	Psychotherapy with chronic inflammatory bowel disease patients: a review.	+	-	nl	Inflamm Bowel Dis 12(12):1175-84 (2006)
19	2006	Recent understanding of IBD pathogenesis: implications for future therapies.	+	-	nl	Inflamm Bowel Dis 12(11):1068-83 (2006)
20	2009	Interleukin-23/Th17 pathways and inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 15(7):1090-100 (2009)
21	2005	The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology.	+	-	nl	Inflamm Bowel Dis 11(3):304-13 (2005)
22	2005	Gastrointestinal parasites: potential therapy for refractory inflammatory bowel diseases.	+	-	nl	Inflamm Bowel Dis 11(2):178-84 (2005)
23	2004	Video capsule endoscopy in inflammatory bowel disease: past, present, and future.	+	-	nl	Inflamm Bowel Dis 10(3):278-85 (2004)
24	2004	Rare extraintestinal manifestations of inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 10(2):140-7 (2004)
25	2004	Ocular manifestations of inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 10(2):135-9 (2004)
26	2004	Pulmonary involvement in Crohn's disease report of a case and review of the literature.	+	-	nl	Inflamm Bowel Dis 10(2):129-34 (2004)
27	2003	Indeterminate colitis.	+	-	nl	Inflamm Bowel Dis 9(5):324-31 (2003)
28	2003	Ten common errors in the management of inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 9(3):205-9 (2003)
29	2003	Pulmonary manifestations of inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 9(2):104-15 (2003)
30	2003	Treatment of inflammatory bowel disease in childhood: best available evidence.	+	-	nl	Inflamm Bowel Dis 9(1):34-58 (2003)
31	2002	Medical management of fulminant colitis.	+	-	nl	Inflamm Bowel Dis 8(2):129-34; discussion 138-9 (2002)
32	2002	Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective.	+	-	nl	Inflamm Bowel Dis 8(2):112-28 (2002)
33	2000	Clinical evaluation and management of acute severe colitis.	+	-	nl	Inflamm Bowel Dis 6(3):214-27 (2000)
34	2000	The key role of macrophages in the immunopathogenesis of inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 6(1):21-33 (2000)
35	1998	Cutaneous manifestations of inflammatory bowel disease.	+	-	nl	Inflamm Bowel Dis 4(2):142-8 (1998)
36	2009	Evidence for a potential role of metallothioneins in inflammatory bowel diseases.	+	-	nl	Mediators Inflamm 2009(-):729172 (2009)
37	1998	Cyclosporine and inflammatory bowel disease: buying time.	+	-	nl	Mediators Inflamm 7(3):145-7 (1998)
38	1998	Azathioprine in inflammatory bowel disease, a safe alternative?	+	-	nl	Mediators Inflamm 7(3):141-4 (1998)
39	1998	The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.	+	-	nl	Mediators Inflamm 7(3):137-40 (1998)
40	1998	Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.	+	-	nl	Mediators Inflamm 7(3):135-6 (1998)
41	1997	Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease.	+	-	nl	Am J Clin Nutr 65(2):564-7 (1997)
42	2007	Review article: Reproduction in the patient with inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 26(4):513-33 (2007)
43	2007	Review article: biological activity markers in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 25(3):247-55 (2007)
44	2007	Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies.	+	-	nl	Aliment Pharmacol Ther 25(2):111-22 (2007)
45	2007	Review article: Indeterminate colitis--definition, diagnosis and management.	+	-	nl	Aliment Pharmacol Ther 25(1):13-7 (2007)
46	2006	Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.	+	-	nl	Aliment Pharmacol Ther 24(10):1403-12 (2006)
47	2006	Review article: thiopurines in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 24(5):715-29 (2006)
48	2006	Systematic review: the use of mesalazine in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 23(7):841-55 (2006)
49	2006	Review article: Infliximab therapy for inflammatory bowel disease--seven years on.	+	-	nl	Aliment Pharmacol Ther 23(4):451-63 (2006)
50	2006	Review article: complementary and alternative therapies for inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 23(3):341-9 (2006)
51	2005	Review article: practical management of inflammatory bowel disease patients taking immunomodulators.	+	-	nl	Aliment Pharmacol Ther 22(1):1-16 (2005)
52	2005	Review article: monitoring of immunomodulators in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 21(4):307-19 (2005)
53	2005	Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature.	+	-	nl	Aliment Pharmacol Ther 21(3):243-9 (2005)
54	2004	Review article: Osteoporosis and inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 19(9):941-52 (2004)
55	2004	Review article: helminths as therapeutic agents for inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 19(2):167-77 (2004)
56	2003	Mycophenolate mofetil in refractory inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 17(11):1365-9 (2003)
57	2002	The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 16(4):693-7 (2002)
58	2002	Review article: faecal markers in the assessment of activity in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 16(4):675-81 (2002)
59	2002	Review article: monitoring for drug side-effects in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 16(4):647-62 (2002)
60	2001	Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.	+	-	nl	Aliment Pharmacol Ther 15(11):1699-708 (2001)
61	2001	Review article: the genetics of inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 15(6):731-48 (2001)
62	2001	Iron and inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 15(4):429-38 (2001)
63	2000	The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.	+	-	nl	Aliment Pharmacol Ther 14(12):1561-5 (2000)
64	2000	Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 14(11):1403-9 (2000)
65	1999	Clinical economics review: medical management of inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 13(1):15-25 (1999)
66	1998	Review article: The management of inflammatory bowel disease during pregnancy.	+	-	nl	Aliment Pharmacol Ther 12(11):1039-53 (1998)
67	1998	Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 12(7):591-603 (1998)
68	2010	Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 31(1):20-34 (2010)
69	2009	Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.	+	-	nl	Aliment Pharmacol Ther 30(6):614-20 (2009)
70	2009	Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?	+	-	nl	Aliment Pharmacol Ther 29(5):459-69 (2009)
71	2009	Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients.	+	-	nl	Aliment Pharmacol Ther 29(3):273-8 (2009)
72	2008	Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 28(6):674-88 (2008)
73	2008	Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception.	+	-	nl	Aliment Pharmacol Ther 27(10):885-94 (2008)
74	2004	Review article: bone disease in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 20 Suppl 4(-):43-9 (2004)
75	2004	Review article: joint involvement in inflammatory bowel disease.	+	-	nl	Aliment Pharmacol Ther 20 Suppl 4(-):36-42 (2004)
76	2002	Review article: a critical approach to new forms of treatment of Crohn's disease and ulcerative colitis.	+	-	nl	Aliment Pharmacol Ther 16 Suppl 4(-):53-8 (2002)
77	1997	Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications.	+	-	nl	Aliment Pharmacol Ther 11(2):237-47 (1997)
78	2008	Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.	+	-	nl	Am J Pathol 172(6):1457-66 (2008)
79	1990	Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier.	+	-	nl	Am J Pathol 137(6):1273-81 (1990)
80	2005	New concepts in the pathophysiology of inflammatory bowel disease.	+	-	nl	Ann Intern Med 143(12):895-904 (2005)
81	2006	Inflammatory bowel disease.	+	-	nl	Arch Dis Child 91(5):426-32 (2006)
82	2006	PPARgamma as a new therapeutic target in inflammatory bowel diseases.	+	-	nl	Gut 55(9):1341-9 (2006)
83	2006	The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.	+	-	nl	Gut 55(6):749-53 (2006)
84	2006	New diagnostic imaging tools for inflammatory bowel disease.	+	-	nl	Gut 55(5):733-41 (2006)
85	2006	Laboratory markers in IBD: useful, magic, or unnecessary toys?	+	-	nl	Gut 55(3):426-31 (2006)
86	2001	Treatment of irritable bowel syndrome: a review of randomised controlled trials.	+	-	nl	Gut 48(2):272-82 (2001)
87	2007	The fundamental basis of inflammatory bowel disease.	+	-	nl	J Clin Invest 117(3):514-21 (2007)
88	2001	Surgical management of ulcerative colitis.	+	-	nl	Swiss Med Wkly 131(23-24):323-37 (2001)
89	2009	Intravenous iron in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 15(37):4666-74 (2009)
90	2009	Anemia and inflammatory bowel diseases.	+	-	nl	World J Gastroenterol 15(37):4659-65 (2009)
91	2009	Role of scintigraphy in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 15(22):2693-700 (2009)
92	2009	Do we really understand what the immunological disturbances in inflammatory bowel disease mean?	+	-	nl	World J Gastroenterol 15(5):521-5 (2009)
93	2008	Surgery for inflammatory bowel disease.	+	-	nl	World J Gastroenterol 14(17):2678-90 (2008) Hwang JM
94	2008	Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.	+	-	nl	World J Gastroenterol 14(13):1972-80 (2008)
95	2008	Special issues in pediatric inflammatory bowel disease.	+	-	nl	World J Gastroenterol 14(3):413-20 (2008) Dubinsky M
96	2008	Recent trends in the surgical management of inflammatory bowel disease.	+	-	nl	World J Gastroenterol 14(3):408-12 (2008) Roses RE
97	2008	Immunopathogenesis of inflammatory bowel disease.	+	-	nl	World J Gastroenterol 14(3):390-400 (2008) Shih DQ
98	2008	Cancer in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 14(3):378-89 (2008) Xie J
99	2008	Treatment of inflammatory bowel disease: a review of medical therapy.	+	-	nl	World J Gastroenterol 14(3):354-77 (2008) Kozuch PL
100	2007	Practical guidelines for the treatment of inflammatory bowel disease.	+	-	nl	World J Gastroenterol 13(8):1149-55 (2007)
101	2006	Probiotics and prebiotics in chronic inflammatory bowel diseases.	+	-	nl	World J Gastroenterol 12(37):5941-50 (2006)
102	2006	Extraintestinal manifestations and complications in inflammatory bowel diseases.	+	-	nl	World J Gastroenterol 12(30):4819-31 (2006)
103	2006	Etiopathogenesis of inflammatory bowel diseases.	+	-	nl	World J Gastroenterol 12(30):4807-12 (2006)
104	2006	Conventional therapy for Crohn's disease.	+	-	nl	World J Gastroenterol 12(30):4794-806 (2006)
105	2006	Antibiotics and probiotics in treatment of inflammatory bowel disease.	+	-	nl	World J Gastroenterol 12(21):3306-13 (2006)
106	2006	Pediatric inflammatory bowel disease.	+	-	nl	World J Gastroenterol 12(20):3204-12 (2006)
107	2005	Extraintestinal manifestations in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 11(46):7227-36 (2005)
108	2004	Drug therapy for ulcerative colitis.	+	-	nl	World J Gastroenterol 10(16):2311-7 (2004)
109	1994	CT findings in inflammatory bowel disease in children.	+	-	nl	AJR Am J Roentgenol 162(4):975-9 (1994)
110	1991	Polypoid and pseudopolypoid manifestations of inflammatory bowel disease.	+	-	nl	Radiographics 11(2):293-304 (1991)
111	2006	CT imaging of colitis.	+	-	nl	Radiology 240(3):623-38 (2006)
112	2010	Comprehensive update on select immune-mediated gastroenterocolitis syndromes: implications for diagnosis and management.	+	-	nl	Radiographics 30(6):1465-87 (2010)
113	2011	Curcumin for inflammatory bowel disease: a review of human studies.	+	-	nl	Altern Med Rev 16(2):152-6 (2011)
114	2003	Molecular discoveries alter our view of inflammatory bowel disease. A review from scientific, clinical, and laboratory perspectives.	+	-	nl	Am J Clin Pathol 119(4):524-39 (2003)
115	2009	T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.	+	-	nl	Am J Physiol Gastrointest Liver Physiol 296(2):G135-46 (2009)
116	2007	Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.	+	-	nl	Am J Physiol Gastrointest Liver Physiol 293(1):G5-G18 (2007)
117	2005	Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease.	+	-	nl	Am J Physiol Gastrointest Liver Physiol 288(3):G417-21 (2005)
118	2011	Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?	+	-	nl	World J Gastroenterol 17(22):2702-7 (2011)
119	2011	Comorbidity in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 17(22):2723-33 (2011)
120	2011	Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.	+	-	nl	World J Gastroenterol 17(23):2791-800 (2011)
121	2011	Innate and adaptive immunity in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 17(27):3178-83 (2011)
122	2011	Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.	+	-	nl	World J Gastroenterol 17(27):3184-91 (2011)
123	2011	Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 17(30):3467-78 (2011)
124	2011	Recent results of laparoscopic surgery in inflammatory bowel disease.	+	-	nl	World J Gastroenterol 17(9):1116-25 (2011)
125	2011	New endoscopic approaches in IBD.	+	-	nl	World J Gastroenterol 17(1):63-8 (2011)
126	2011	Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.	+	-	nl	World J Gastroenterol 17(5):547-56 (2011)
127	2011	Extraluminal factors contributing to inflammatory bowel disease.	+	-	nl	World J Gastroenterol 17(5):572-7 (2011)
128	2011	Role of the endothelium in inflammatory bowel diseases.	+	-	nl	World J Gastroenterol 17(5):578-93 (2011)
129	2011	Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.	+	-	nl	World J Gastroenterol 17(5):594-608 (2011)
130	2011	Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.	+	-	nl	World J Gastroenterol 17(37):4166-73 (2011)
131	2009	Inflammatory bowel disease-associated spondyloarthropathies.	+	-	nl	World J Gastroenterol 15(20):2441-2 (2009)
132	2009	Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.	+	-	nl	World J Gastroenterol 15(20):2449-55 (2009) Salvarani C
133	2009	Rheumatic manifestations of inflammatory bowel disease.	+	-	nl	World J Gastroenterol 15(44):5517-24 (2009)
134	2007	Thoracic manifestations of inflammatory bowel disease.	+	-	nl	Chest 131(2):524-32 (2007)
135	2011	The multifaceted role of the inflammasome in inflammatory bowel diseases.	+	-	nl	ScientificWorldJournal 11(-):1536-47 (2011)
136	2002	Clinical aspects and pathophysiology of inflammatory bowel disease.	+	-	nl	Clin Microbiol Rev 15(1):79-94 (2002)
137	2004	Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.	+	-	nl	Isr Med Assoc J 6(4):221-6 (2004)
138	2008	Novel therapeutic modalities in pediatric inflammatory bowel disease.	+	-	nl	Isr Med Assoc J 10(11):816-20 (2008)
139	2005	Important cutaneous manifestations of inflammatory bowel disease.	+	-	nl	Postgrad Med J 81(959):580-5 (2005)
140	2004	Management of inflammatory bowel disease.	+	-	nl	Postgrad Med J 80(942):206-13 (2004)
141	2011	Treatment of inflammatory bowel disease (IBD).	+	-	nl	Pharmacol Rep 63(3):629-42 (2011)
142	2007	Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.	+	-	nl	MedGenMed 9(1):55 (2007)
143	2009	TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide.	+	-	nl	Swiss Med Wkly 139(19-20):278-87 (2009)
144	2009	Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?	+	-	nl	Gastroenterol Clin Biol 33 Suppl 3(-):S202-8 (2009)
145	2009	New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?	+	-	nl	Gastroenterol Clin Biol 33 Suppl 3(-):S217-27 (2009)
146	2009	Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?	+	-	nl	Gastroenterol Clin Biol 33 Suppl 3(-):S228-34 (2009)
147	2009	Biological markers in inflammatory bowel disease: practical consideration for clinicians.	+	-	nl	Gastroenterol Clin Biol 33 Suppl 3(-):S158-73 (2009)
148	2009	Imaging techniques in inflammatory bowel disease: recent trends, questions and answers.	+	-	nl	Gastroenterol Clin Biol 33 Suppl 3(-):S174-82 (2009)
149	2009	Wireless capsule in inflammatory bowel disease.	+	-	nl	Gastroenterol Clin Biol 33 Suppl 3(-):S183-9 (2009)
150	2002	Sexual abuse in irritable bowel syndrome: to ask or not to ask -- that is the question.	+	-	nl	Can J Gastroenterol 16(11):801-5 (2002)
151	2009	Relevance of segmental colitis with diverticulosis (SCAD) to other forms of inflammatory bowel disease.	+	-	nl	Can J Gastroenterol 23(6):439-40 (2009)
152	2004	Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?	+	-	nl	Clin Dev Immunol 11(3-4):195-204 (2004)
153	2011	Inhibition of histone deacetylases in inflammatory bowel diseases.	+	-	nl	Mol Med 17(5-6):426-33 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.